Research Article
A Multicenter Trial Defining a Serum Protein Signature Associated with Pancreatic Ductal Adenocarcinoma
Table 1
Characteristics of the PANKRAS II study subjects according to the groups considered in the comparative analysis.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
() ICD9 codes: 454 (2), 540, 735 (2), 807, 808, 812, 813, 820, 550.9 (4), 553.21 (2), 553.3, 560.9, 603.9, 735.0, 806.4, 812.09, 815.02, 820.2, 820.8, 821.2, 823.0, 823.90, 824.0, 839.0. |